Volume 17 - Issue 7 - July, 2005
Feature
Vascular Disease
08/01/2008
Jeffrey M. Friedel, MD, Ramzi Khalil, MD, David Lasorda, MD
Jeffrey M. Friedel, MD, Ramzi Khalil...
Iatrogenic renal artery perforation is a rare, but well-described complication of percutaneous renal artery intervention.1–3 Treatment has traditionally involved surgical intervention including renal artery reconstruction, bypass grafting,...
Iatrogenic renal artery perforation is a rare, but well-described complication of percutaneous renal artery intervention.1–3 Treatment has traditionally involved surgical intervention including renal artery reconstruction, bypass grafting,...
Iatrogenic renal artery...
08/01/2008
Journal of Invasive Cardiology
Case Report
08/01/2008
Stefano Rigattieri, MD, PhD, Martial Hamon, MD, FESC, Gilles Grollier, MD
Stefano Rigattieri, MD, PhD, Martial...
The transradial approach for percutaneous coronary interventions represents an effective and safe alternative to the traditional transfemoral approach, allowing earlier ambulation and discharge, greater comfort for the patient, and less...
The transradial approach for percutaneous coronary interventions represents an effective and safe alternative to the traditional transfemoral approach, allowing earlier ambulation and discharge, greater comfort for the patient, and less...
The transradial approach for...
08/01/2008
Journal of Invasive Cardiology
Case Report
08/01/2008
Woong Chol Kang, MD, Seung Hwan Han, MD, Kyung Rim Choi, MD, Tae Hoon Ahn, MD, Eak Kyun Shin, MD
Woong Chol Kang, MD, Seung Hwan Han,...
Since the use of combined antiplatelet therapy with aspirin and thienopyridines, the incidence of stent thrombosis is uncommon. Moreover, late stent thrombosis (> 30 days after stent implantation) is extremely rare with bare metal stents...
Since the use of combined antiplatelet therapy with aspirin and thienopyridines, the incidence of stent thrombosis is uncommon. Moreover, late stent thrombosis (> 30 days after stent implantation) is extremely rare with bare metal stents...
Since the use of combined...
08/01/2008
Journal of Invasive Cardiology
Review
08/01/2008
Enio E. Guérios, MD, PhD, Ronaldo Bueno, MD, PhD, Deborah Nercolini, MD, José Tarastchuk, MD, Paulo Andrade, MD, Alvaro Pacheco, MD, Alysson Faidiga, MD, Stefan Negrao, MD*, Antonio Barbosa, MD*
Enio E. Guérios, MD, PhD, Ronaldo B...
The prevailing cause of mitral stenosis (MS) is a progressive reaction to an injury caused by one of the major manifestations of rheumatic fever (RF): rheumatic carditis. The mitral is the valve most commonly prone to suffer a rheumatic...
The prevailing cause of mitral stenosis (MS) is a progressive reaction to an injury caused by one of the major manifestations of rheumatic fever (RF): rheumatic carditis. The mitral is the valve most commonly prone to suffer a rheumatic...
The prevailing cause of mitral...
08/01/2008
Journal of Invasive Cardiology
Case Report
08/01/2008
Worawut Tassanawiwat, MD, Ioannis Iakovou, MD,* Antonio Colombo, MD*
Worawut Tassanawiwat, MD, Ioannis Ia...
Atherosclerotic coronary artery disease is infrequently associated with ectasia and aneurysms due to extreme positive remodelling.1 Coronary artery aneurysms have been excluded with coil embolization, autologous saphenous vein-covered stent...
Atherosclerotic coronary artery disease is infrequently associated with ectasia and aneurysms due to extreme positive remodelling.1 Coronary artery aneurysms have been excluded with coil embolization, autologous saphenous vein-covered stent...
Atherosclerotic coronary artery...
08/01/2008
Journal of Invasive Cardiology
Case Report
08/01/2008
Robert J. Applegate, MD, Teresa Draughn, MD, Brent Davis, MD
Robert J. Applegate, MD, Teresa Drau...
The optimal treatment of bifurcation disease remains a challenging clinical problem.1 Although numerous techniques and strategies have been explored and reported,2–7 including “crushing” a drug-eluting stent with another drug-eluting stent,...
The optimal treatment of bifurcation disease remains a challenging clinical problem.1 Although numerous techniques and strategies have been explored and reported,2–7 including “crushing” a drug-eluting stent with another drug-eluting stent,...
The optimal treatment of...
08/01/2008
Journal of Invasive Cardiology
Case Report
08/01/2008
Wercules Oliveira, MD, George C. Meireles, MD, Joao Pimenta, MD, PhD
Wercules Oliveira, MD, George C. Mei...
Myelodysplastic syndrome is a clonal hematopoietic stem-cell disorder characterized by cytopenia caused by inadequate proliferation and differentiation of blood cells due to dysmorphic or abnormal cellular bone marrow. When the megakaryocytic...
Myelodysplastic syndrome is a clonal hematopoietic stem-cell disorder characterized by cytopenia caused by inadequate proliferation and differentiation of blood cells due to dysmorphic or abnormal cellular bone marrow. When the megakaryocytic...
Myelodysplastic syndrome is a...
08/01/2008
Journal of Invasive Cardiology
IAGS (International Andreas Gruentzig Society) Proceedings
08/01/2008
Speaker: David Holmes, MD
Moderator: Reginald Low, MD
Panel members: George Dangas, MD, Wolfgang Ritter, MD, Peter Gonschior, MD, Brian Firth (Cordis Corporation)
Speaker: David Holmes, MD
Moderator:...
George Dangas: There have been many attempts and many failures in this field due perhaps to the inherent tendency of interventional cardiologists to move quickly and work from assumptions, applying what may not yet be well understood. Gene...
George Dangas: There have been many attempts and many failures in this field due perhaps to the inherent tendency of interventional cardiologists to move quickly and work from assumptions, applying what may not yet be well understood. Gene...
George Dangas: There have been...
08/01/2008
Journal of Invasive Cardiology
IAGS (International Andreas Gruentzig Society) Proceedings
08/01/2008
William O’Neill: I have a couple of questions for both of you. First, we are essentially talking about adult, autologous stem cells. As you all know, there is enormous controversy in the U.S. about the use of embryonic stem cells which we are...
William O’Neill: I have a couple of questions for both of you. First, we are essentially talking about adult, autologous stem cells. As you all know, there is enormous controversy in the U.S. about the use of embryonic stem cells which we are...
William O’Neill: I have a couple...
08/01/2008
Journal of Invasive Cardiology
Insights
Commentary
08/01/2008
Kimberly A. Skelding, MD and John J. Young, MD
Kimberly A. Skelding, MD and John J. ...
There are more than 150 million adults worldwide estimated to have diabetes mellitus (DM), with Type 2 diabetes accounting for up to 95% of all cases.1 In 2001, the prevalence of DM in the United States was 8%, a relative increase of...
There are more than 150 million adults worldwide estimated to have diabetes mellitus (DM), with Type 2 diabetes accounting for up to 95% of all cases.1 In 2001, the prevalence of DM in the United States was 8%, a relative increase of...
There are more than 150 million...
08/01/2008
Journal of Invasive Cardiology
